PharmaCyte Biotech, Inc.
PMCB
$0.94
$0.044.34%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.12% | -44.70% | -69.03% | -72.63% | -71.62% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.01% | -0.83% | -13.86% | -30.36% | 52.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.92% | -41.88% | -55.64% | -72.42% | -71.07% |
|
|
|||||
| Total Current Assets | 7.92% | -41.88% | -55.64% | -72.42% | -71.07% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | -56.35% | -56.35% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.79% | -27.52% | 10.80% | 41.36% | 95,493.51% |
| Total Assets | 1.59% | -35.73% | -7.91% | -38.58% | -30.15% |
|
|
|||||
| Total Accounts Payable | 192.97% | -16.03% | 2.52% | 0.14% | 176.23% |
| Total Accrued Expenses | -51.12% | -49.47% | -29.12% | -8.39% | -30.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -94.34% | -95.99% | -68.33% | -- | 547.72% |
| Total Other Current Liabilities | -94.34% | -95.99% | -68.33% | -- | 547.72% |
| Total Current Liabilities | -66.97% | -85.80% | -60.73% | -46.91% | 177.88% |
|
|
|||||
| Total Current Liabilities | -66.97% | -85.80% | -60.73% | -46.91% | 177.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 159.71% | -95.27% | -97.20% | -84.03% | -55.88% |
| Total Liabilities | 66.76% | -91.14% | -83.93% | -79.17% | -32.64% |
|
|
|||||
| Common Stock & APIC | -0.41% | -0.64% | -2.07% | -4.12% | -6.32% |
| Retained Earnings | -7.55% | -1.22% | 26.51% | 17.31% | 19.49% |
| Treasury Stock & Other | 0.04% | -4.25% | -6.11% | -8.76% | -9.28% |
| Total Common Equity | -17.95% | -8.63% | 87.69% | 28.29% | 18.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.95% | -8.63% | 87.69% | 28.29% | 18.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.87% | -17.82% | 31.32% | -25.71% | -29.45% |
|
|
|||||